The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands

International Immunology

Volumn 18, Issue 12, 2006, Pages 1729-1736

  Kandler, Kerstin ^a   Shaykhiev, Renat ^a   Kleemann, Peter ^b   Klescz, Frank ^a   Lohoff, Michael ^b   Vogelmeier, Claus ^a   Bals, Robert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FLAGELLIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MONOCYTES; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 33845364149     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl107     Document Type: Article

References (33)

1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Medzhitov, R. and Janeway, C. J. Jr. 2000. Advances in immunology: innate immunity. N. Engl. J. Med. 343:338.
3. Pulendran, B., Palucka, K. and Banchereau, J. 2001. Sensing pathogens and tuning immune responses. Science 293:253.
4. Soumelis, V., Reche, P. A., Kanzler, H. et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673.
5. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389.
6. Ganz, T. 1999. Defensins and host defense. Science 286:420.
7. Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J. and Oppenheim, J. J. 2004. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22:181.
8. Brown, K. L. and Hancock, R. E. 2006. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18:24.
9. Zanetti, M., Gennaro, R. and Romeo, D. 1995. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1.
10. Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B. and Salcedo, R. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325.
11. Cowland, J., Johnsen, A. and Borregaard, N. 1995. hCAP-18, a cathelin/ pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368:173.
12. Sorensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F. and Borregaard, N. 1997. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90: 2796.
13. Frohm, M., Agerberth, B., Ahangari, G. et al. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258.
14. Agerberth, B., Charo, J., Werr, J. et al. 2000. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086.
15. Bals, R., Wang, X., Zasloff, M. and Wilson, J. M. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl Acad. Sci. USA 95:9541.
16. Koczulla, R., von Degenfeld, G., Kupatt, C. et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111:1665.
17. Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H. and Nagaoka, I. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/ -2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31:1066.
18. Bowdish, D. M., Davidson, D. J., Speert, D. P. and Hancock, R. E. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172:3758.
19. Davidson, D. J., Currie, A. J., Reid, G. S. et al. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172: 1146.
20. Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D. and Hancock, R. E. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883.
21. Shaykhiev, R., Beisswenger, C., Kaendler, K. et al. 2005. The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:842.
22. Agerberth, B., Grunewald, J. and Castanos-Velez, E. 1999. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160:283.
23. Schaller-Bals, S., Schulze, A. and Bals, R. 2002. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am. J. Respir. Crit. Care Med. 165:992.
24. An, L. L., Yang, Y. H., Ma, X. T. et al. 2005. LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine. Leuk. Res. 29:535.
25. Mookherjee, N., Brown, K. L., Bowdish, D. M. et al. 2006. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176: 2455.
26. Message, S. D. and Johnston, S. L. 2004. Host defense function of the airway epithelium in health and disease: Clinical background. J. Leukoc. Biol. 75:5.
27. Cookson, W. 2004. The immunogenetics of asthma and eczema: A new focus on the epithelium. Nat. Rev. Immunol. 4:978.
28. Yang, D., Chertov, O., Bykovskaia, S. et al. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525.
29. Bowdish, D. M., Davidson, D. J., Scott, M. G. and Hancock, R. E. 2005. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49:1727.
30. Yang, D., Chen, Q., Schmidt, A. P. et al. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemo-attract human peripheral blood neutrophils, monocytes, and T-cells. J. Exp. Med. 192:1069.
31. Elssner, A., Duncan, M., Gavrilin, M. and Wewers, M. D. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172:4987.
32. Tjabringa, G. S., Aarbiou, J., Ninaber, D. K. et al. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171:6690.
33. Kang, H. K., Lee, H. Y., Kim, M. K. et al. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175:685.